HEADER CHAPERONE/INHIBITOR 28-FEB-22 7U4C TITLE BORRELIA BURGDORFERI HTPG N-TERMINAL DOMAIN (1-228) IN COMPLEX WITH TITLE 2 BX-2819 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHAPERONE PROTEIN HTPG; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HEAT SHOCK PROTEIN HTPG,HIGH TEMPERATURE PROTEIN G; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BORRELIELLA BURGDORFERI; SOURCE 3 ORGANISM_COMMON: LYME DISEASE SPIROCHETE; SOURCE 4 ORGANISM_TAXID: 139; SOURCE 5 GENE: HTPG, BB_0560; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS INHIBITOR, CHAPERONE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.E.KOWALEWSKI,A.LIETZAN,T.HAYSTEAD,M.R.REDINBO REVDAT 4 15-NOV-23 7U4C 1 JRNL REVDAT 3 08-NOV-23 7U4C 1 JRNL REVDAT 2 25-OCT-23 7U4C 1 REMARK REVDAT 1 08-MAR-23 7U4C 0 JRNL AUTH D.L.CARLSON,M.KOWALEWSKI,K.BODOOR,A.D.LIETZAN,P.F.HUGHES, JRNL AUTH 2 D.GOODEN,D.L.LOISELLE,D.ALCORTA,Z.DINGMAN,E.A.MUELLER, JRNL AUTH 3 I.IRNOV,S.MODLA,T.CHAYA,J.CAPLAN,M.EMBERS,J.C.MILLER, JRNL AUTH 4 C.JACOBS-WAGNER,M.R.REDINBO,N.SPECTOR,T.A.J.HAYSTEAD JRNL TITL TARGETING BORRELIA BURGDORFERI HTPG WITH A BERSERKER JRNL TITL 2 MOLECULE, A STRATEGY FOR ANTI-MICROBIAL DEVELOPMENT. JRNL REF CELL CHEM BIOL 2023 JRNL REFN ESSN 2451-9456 JRNL PMID 37918401 JRNL DOI 10.1016/J.CHEMBIOL.2023.10.004 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 19888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.0300 - 5.4900 0.99 1391 157 0.2070 0.2120 REMARK 3 2 5.4900 - 4.3600 0.99 1309 144 0.1736 0.1842 REMARK 3 3 4.3600 - 3.8100 0.99 1287 141 0.1811 0.1912 REMARK 3 4 3.8100 - 3.4600 0.99 1279 148 0.1840 0.1977 REMARK 3 5 3.4600 - 3.2100 1.00 1302 138 0.2000 0.2788 REMARK 3 6 3.2100 - 3.0200 1.00 1274 137 0.2154 0.2429 REMARK 3 7 3.0200 - 2.8700 1.00 1262 146 0.2302 0.2688 REMARK 3 8 2.8700 - 2.7500 1.00 1260 145 0.2391 0.2621 REMARK 3 9 2.7500 - 2.6400 1.00 1247 139 0.2290 0.2748 REMARK 3 10 2.6400 - 2.5500 1.00 1282 146 0.2183 0.2534 REMARK 3 11 2.5500 - 2.4700 1.00 1253 138 0.2410 0.2998 REMARK 3 12 2.4700 - 2.4000 1.00 1246 135 0.2411 0.3048 REMARK 3 13 2.4000 - 2.3400 1.00 1260 151 0.2575 0.3125 REMARK 3 14 2.3400 - 2.2800 1.00 1238 133 0.2614 0.3023 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.257 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.359 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3200 REMARK 3 ANGLE : 0.401 4333 REMARK 3 CHIRALITY : 0.041 491 REMARK 3 PLANARITY : 0.002 543 REMARK 3 DIHEDRAL : 10.462 453 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7U4C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000263440. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19889 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 48.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.04970 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.27390 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.460 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.20_4459 REMARK 200 STARTING MODEL: PDB ENTRY 3HHU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE, 0.1 M BIS REMARK 280 -TRIS HCL, PH 5.5, 22.5% PEG3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.19250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.51950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.21400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.51950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.19250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 26.21400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 LYS A 3 REMARK 465 GLN A 4 REMARK 465 PHE A 5 REMARK 465 SER A 94 REMARK 465 GLY A 95 REMARK 465 MET A 209 REMARK 465 LYS A 210 REMARK 465 ASP A 211 REMARK 465 GLY A 212 REMARK 465 LYS A 213 REMARK 465 GLN A 214 REMARK 465 GLU A 215 REMARK 465 GLY A 216 REMARK 465 ILE A 217 REMARK 465 GLU A 218 REMARK 465 GLU A 219 REMARK 465 LYS A 220 REMARK 465 GLU A 221 REMARK 465 GLU A 222 REMARK 465 LYS A 223 REMARK 465 LEU A 224 REMARK 465 ASN A 225 REMARK 465 GLU A 226 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 GLY A 230 REMARK 465 GLU A 231 REMARK 465 ASN A 232 REMARK 465 LEU A 233 REMARK 465 TYR A 234 REMARK 465 PHE A 235 REMARK 465 ILE B 55 REMARK 465 ALA B 56 REMARK 465 LYS B 210 REMARK 465 ASP B 211 REMARK 465 GLY B 212 REMARK 465 LYS B 213 REMARK 465 GLN B 214 REMARK 465 GLU B 215 REMARK 465 GLY B 216 REMARK 465 ILE B 217 REMARK 465 GLU B 218 REMARK 465 GLU B 219 REMARK 465 LYS B 220 REMARK 465 GLU B 221 REMARK 465 GLU B 222 REMARK 465 LYS B 223 REMARK 465 LEU B 224 REMARK 465 ASN B 225 REMARK 465 GLU B 226 REMARK 465 GLY B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 GLY B 230 REMARK 465 GLU B 231 REMARK 465 ASN B 232 REMARK 465 LEU B 233 REMARK 465 TYR B 234 REMARK 465 PHE B 235 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 6 N CB CG OD1 OD2 REMARK 470 THR A 7 OG1 CG2 REMARK 470 GLU A 8 CG CD OE1 OE2 REMARK 470 LEU A 13 CG CD1 CD2 REMARK 470 GLU A 25 CG CD OE1 OE2 REMARK 470 GLU A 30 CG CD OE1 OE2 REMARK 470 GLU A 58 CG CD OE1 OE2 REMARK 470 ASP A 67 CG OD1 OD2 REMARK 470 LYS A 93 CG CD CE NZ REMARK 470 THR A 96 OG1 CG2 REMARK 470 LYS A 97 CG CD CE NZ REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 LYS A 109 CE NZ REMARK 470 LYS A 151 CG CD CE NZ REMARK 470 GLU A 155 CG CD OE1 OE2 REMARK 470 LYS A 174 CG CD CE NZ REMARK 470 LYS A 182 CG CD CE NZ REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 ASN A 194 CG OD1 ND2 REMARK 470 HIS A 195 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 206 CG CD OE1 OE2 REMARK 470 ILE A 208 CG1 CG2 CD1 REMARK 470 MET B 0 CG SD CE REMARK 470 MET B 1 CG SD CE REMARK 470 LYS B 2 CG CD CE NZ REMARK 470 LYS B 3 CG CD CE NZ REMARK 470 ASP B 6 CG OD1 OD2 REMARK 470 GLU B 25 CG CD OE1 OE2 REMARK 470 LEU B 45 CG CD1 CD2 REMARK 470 GLU B 50 CG CD OE1 OE2 REMARK 470 LYS B 51 CG CD CE NZ REMARK 470 LYS B 53 CG CD CE NZ REMARK 470 ASN B 54 CG OD1 ND2 REMARK 470 LEU B 57 CG CD1 CD2 REMARK 470 GLU B 58 CG CD OE1 OE2 REMARK 470 LYS B 60 CG CD CE NZ REMARK 470 ASP B 67 CG OD1 OD2 REMARK 470 LYS B 68 CG CD CE NZ REMARK 470 GLU B 81 CG CD OE1 OE2 REMARK 470 GLN B 82 CG CD OE1 NE2 REMARK 470 VAL B 90 CG1 CG2 REMARK 470 ILE B 91 CG1 CG2 CD1 REMARK 470 LYS B 93 CG CD CE NZ REMARK 470 SER B 94 OG REMARK 470 THR B 96 OG1 CG2 REMARK 470 LYS B 97 CG CD CE NZ REMARK 470 GLU B 98 CG CD OE1 OE2 REMARK 470 LYS B 108 CG CD CE NZ REMARK 470 GLN B 116 CG CD OE1 NE2 REMARK 470 GLU B 155 CG CD OE1 OE2 REMARK 470 GLU B 157 CG CD OE1 OE2 REMARK 470 LYS B 158 CG CD CE NZ REMARK 470 LYS B 160 CG CD CE NZ REMARK 470 GLU B 162 CG CD OE1 OE2 REMARK 470 GLU B 163 CG CD OE1 OE2 REMARK 470 LYS B 182 CG CD CE NZ REMARK 470 TRP B 183 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 183 CZ3 CH2 REMARK 470 GLU B 187 CG CD OE1 OE2 REMARK 470 LYS B 190 CG CD CE NZ REMARK 470 LYS B 191 CG CD CE NZ REMARK 470 HIS B 195 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 203 CG CD CE NZ REMARK 470 MET B 209 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 40 OH TYR A 198 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 21 32.92 -94.13 REMARK 500 SER A 22 -64.82 -148.40 REMARK 500 ALA A 56 79.45 -110.83 REMARK 500 ASP A 66 -143.41 -117.05 REMARK 500 ASN A 75 44.31 -107.11 REMARK 500 LYS A 151 -65.65 -128.87 REMARK 500 ASP B 66 -140.97 -126.11 REMARK 500 ASN B 75 52.02 -102.50 REMARK 500 ILE B 91 84.24 -150.24 REMARK 500 LEU B 139 -19.03 69.46 REMARK 500 REMARK 500 REMARK: NULL DBREF 7U4C A 1 226 UNP P42555 HTPG_BORBU 1 226 DBREF 7U4C B 1 226 UNP P42555 HTPG_BORBU 1 226 SEQADV 7U4C MET A 0 UNP P42555 INITIATING METHIONINE SEQADV 7U4C GLY A 227 UNP P42555 EXPRESSION TAG SEQADV 7U4C SER A 228 UNP P42555 EXPRESSION TAG SEQADV 7U4C SER A 229 UNP P42555 EXPRESSION TAG SEQADV 7U4C GLY A 230 UNP P42555 EXPRESSION TAG SEQADV 7U4C GLU A 231 UNP P42555 EXPRESSION TAG SEQADV 7U4C ASN A 232 UNP P42555 EXPRESSION TAG SEQADV 7U4C LEU A 233 UNP P42555 EXPRESSION TAG SEQADV 7U4C TYR A 234 UNP P42555 EXPRESSION TAG SEQADV 7U4C PHE A 235 UNP P42555 EXPRESSION TAG SEQADV 7U4C MET B 0 UNP P42555 INITIATING METHIONINE SEQADV 7U4C GLY B 227 UNP P42555 EXPRESSION TAG SEQADV 7U4C SER B 228 UNP P42555 EXPRESSION TAG SEQADV 7U4C SER B 229 UNP P42555 EXPRESSION TAG SEQADV 7U4C GLY B 230 UNP P42555 EXPRESSION TAG SEQADV 7U4C GLU B 231 UNP P42555 EXPRESSION TAG SEQADV 7U4C ASN B 232 UNP P42555 EXPRESSION TAG SEQADV 7U4C LEU B 233 UNP P42555 EXPRESSION TAG SEQADV 7U4C TYR B 234 UNP P42555 EXPRESSION TAG SEQADV 7U4C PHE B 235 UNP P42555 EXPRESSION TAG SEQRES 1 A 236 MET MET LYS LYS GLN PHE ASP THR GLU VAL ASN ASP LEU SEQRES 2 A 236 LEU TYR LEU ILE ILE HIS SER LEU TYR SER HIS LYS GLU SEQRES 3 A 236 ILE PHE LEU ARG GLU LEU ILE SER ASN ALA SER ASP ALA SEQRES 4 A 236 ILE ASP LYS LEU LYS PHE LEU SER LEU THR ASN GLU LYS SEQRES 5 A 236 PHE LYS ASN ILE ALA LEU GLU PRO LYS ILE GLU ILE SER SEQRES 6 A 236 PHE ASP ASP LYS SER ILE LEU ILE LYS ASP ASN GLY ILE SEQRES 7 A 236 GLY MET ASP GLU GLN ASP LEU THR ASN HIS LEU GLY VAL SEQRES 8 A 236 ILE ALA LYS SER GLY THR LYS GLU PHE ILE ASN ASN LEU SEQRES 9 A 236 LYS GLN ASP GLU LYS LYS SER ALA SER LEU ILE GLY GLN SEQRES 10 A 236 PHE GLY VAL GLY PHE TYR SER ALA PHE ILE VAL SER GLU SEQRES 11 A 236 LYS VAL GLU VAL THR SER LYS LYS ALA LEU GLU SER ASP SEQRES 12 A 236 ALA TYR ILE TRP SER SER ASP GLY LYS THR GLY TYR GLU SEQRES 13 A 236 ILE GLU LYS ALA LYS LYS GLU GLU SER GLY THR GLU ILE SEQRES 14 A 236 LYS LEU TYR LEU ASN LYS GLU GLY LEU GLU TYR ALA ASN SEQRES 15 A 236 LYS TRP LYS ILE GLN GLU ILE ILE LYS LYS TYR SER ASN SEQRES 16 A 236 HIS ILE ASN TYR PRO ILE TYR ILE LYS TYR SER GLU PRO SEQRES 17 A 236 ILE MET LYS ASP GLY LYS GLN GLU GLY ILE GLU GLU LYS SEQRES 18 A 236 GLU GLU LYS LEU ASN GLU GLY SER SER GLY GLU ASN LEU SEQRES 19 A 236 TYR PHE SEQRES 1 B 236 MET MET LYS LYS GLN PHE ASP THR GLU VAL ASN ASP LEU SEQRES 2 B 236 LEU TYR LEU ILE ILE HIS SER LEU TYR SER HIS LYS GLU SEQRES 3 B 236 ILE PHE LEU ARG GLU LEU ILE SER ASN ALA SER ASP ALA SEQRES 4 B 236 ILE ASP LYS LEU LYS PHE LEU SER LEU THR ASN GLU LYS SEQRES 5 B 236 PHE LYS ASN ILE ALA LEU GLU PRO LYS ILE GLU ILE SER SEQRES 6 B 236 PHE ASP ASP LYS SER ILE LEU ILE LYS ASP ASN GLY ILE SEQRES 7 B 236 GLY MET ASP GLU GLN ASP LEU THR ASN HIS LEU GLY VAL SEQRES 8 B 236 ILE ALA LYS SER GLY THR LYS GLU PHE ILE ASN ASN LEU SEQRES 9 B 236 LYS GLN ASP GLU LYS LYS SER ALA SER LEU ILE GLY GLN SEQRES 10 B 236 PHE GLY VAL GLY PHE TYR SER ALA PHE ILE VAL SER GLU SEQRES 11 B 236 LYS VAL GLU VAL THR SER LYS LYS ALA LEU GLU SER ASP SEQRES 12 B 236 ALA TYR ILE TRP SER SER ASP GLY LYS THR GLY TYR GLU SEQRES 13 B 236 ILE GLU LYS ALA LYS LYS GLU GLU SER GLY THR GLU ILE SEQRES 14 B 236 LYS LEU TYR LEU ASN LYS GLU GLY LEU GLU TYR ALA ASN SEQRES 15 B 236 LYS TRP LYS ILE GLN GLU ILE ILE LYS LYS TYR SER ASN SEQRES 16 B 236 HIS ILE ASN TYR PRO ILE TYR ILE LYS TYR SER GLU PRO SEQRES 17 B 236 ILE MET LYS ASP GLY LYS GLN GLU GLY ILE GLU GLU LYS SEQRES 18 B 236 GLU GLU LYS LEU ASN GLU GLY SER SER GLY GLU ASN LEU SEQRES 19 B 236 TYR PHE HET 819 A 301 30 HET 819 B 301 30 HETNAM 819 ETHYL (4-{3-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]-5- HETNAM 2 819 SULFANYL-4H-1,2,4-TRIAZOL-4-YL}BENZYL)CARBAMATE FORMUL 3 819 2(C21 H24 N4 O4 S) FORMUL 5 HOH *120(H2 O) HELIX 1 AA1 ASP A 6 TYR A 21 1 16 HELIX 2 AA2 HIS A 23 PHE A 27 5 5 HELIX 3 AA3 LEU A 28 ASN A 49 1 22 HELIX 4 AA4 GLU A 50 LYS A 53 5 4 HELIX 5 AA5 ASP A 80 LEU A 88 1 9 HELIX 6 AA6 LYS A 97 ASP A 106 1 10 HELIX 7 AA7 ASP A 106 GLY A 118 1 13 HELIX 8 AA8 VAL A 119 ILE A 126 5 8 HELIX 9 AA9 GLY A 176 ALA A 180 5 5 HELIX 10 AB1 ASN A 181 SER A 193 1 13 HELIX 11 AB2 ASP B 6 SER B 19 1 14 HELIX 12 AB3 HIS B 23 GLU B 25 5 3 HELIX 13 AB4 ILE B 26 THR B 48 1 23 HELIX 14 AB5 ASN B 49 LYS B 53 5 5 HELIX 15 AB6 ASP B 80 LEU B 88 1 9 HELIX 16 AB7 LYS B 93 LYS B 104 1 12 HELIX 17 AB8 ASP B 106 GLY B 118 1 13 HELIX 18 AB9 VAL B 119 TYR B 122 5 4 HELIX 19 AC1 SER B 123 VAL B 127 1 5 HELIX 20 AC2 GLY B 176 ALA B 180 5 5 HELIX 21 AC3 ASN B 181 SER B 193 1 13 SHEET 1 AA115 TYR A 154 ALA A 159 0 SHEET 2 AA115 ALA A 143 SER A 148 -1 N ILE A 145 O GLU A 157 SHEET 3 AA115 SER A 128 LYS A 136 -1 N VAL A 133 O TRP A 146 SHEET 4 AA115 GLY A 165 LEU A 172 -1 O GLU A 167 N THR A 134 SHEET 5 AA115 SER A 69 ASP A 74 -1 N ILE A 70 O LEU A 170 SHEET 6 AA115 ILE A 61 PHE A 65 -1 N SER A 64 O LEU A 71 SHEET 7 AA115 ILE A 200 PRO A 207 1 O TYR A 201 N ILE A 63 SHEET 8 AA115 ILE B 200 PRO B 207 -1 O ILE B 202 N GLU A 206 SHEET 9 AA115 ILE B 61 PHE B 65 1 N ILE B 61 O TYR B 201 SHEET 10 AA115 SER B 69 ASP B 74 -1 O LEU B 71 N SER B 64 SHEET 11 AA115 GLY B 165 LEU B 172 -1 O LEU B 170 N ILE B 70 SHEET 12 AA115 SER B 128 LYS B 136 -1 N THR B 134 O GLU B 167 SHEET 13 AA115 ALA B 143 SER B 148 -1 O TRP B 146 N VAL B 133 SHEET 14 AA115 TYR B 154 ALA B 159 -1 O ALA B 159 N ALA B 143 SHEET 15 AA115 MET B 1 LYS B 3 -1 N LYS B 3 O TYR B 154 CRYST1 50.385 52.428 159.039 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019847 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006288 0.00000